Renaissance Technologies
SMMT icon

Renaissance Technologies’s Summit Therapeutics SMMT Stock Holding History

Renaissance Technologies’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,300
Closed -$99K – 4353
2022
Q4 		$99K Buy
+23,300
New +$42.4K ﹤0.01% 3622
2022
Q3 		– Sell
-49,118
Closed -$49K – 4371
2022
Q2 		$49K Buy
+49,118
New +$68.9K ﹤0.01% 4000
2021
Q3 		– Sell
-125,452
Closed -$936K – 3811
2021
Q2 		$936K Buy
125,452
+56,840
+83% +$373K ﹤0.01% 2696
2021
Q1 		$403K Sell
68,612
-184,600
-73% -$1.19M ﹤0.01% 2987
2020
Q4 		$1.19M Sell
253,212
-50,200
-17% -$213K ﹤0.01% 2417
2020
Q3 		$1.04M Sell
303,412
-57,700
-16% -$200K ﹤0.01% 2497
2020
Q2 		$1.07M Buy
361,112
+191,813
+113% +$662K ﹤0.01% 2505
2020
Q1 		$401K Sell
169,299
-20,535
-11% -$35.3K ﹤0.01% 2863
2019
Q4 		$304K Buy
189,834
+77,728
+69% +$125K ﹤0.01% 3068
2019
Q3 		$201K Buy
112,106
+27,576
+33% +$37.3K ﹤0.01% 3145
2019
Q2 		$107K Buy
84,530
+8,200
+11% +$13.7K ﹤0.01% 3388
2019
Q1 		$140K Buy
76,330
+27,230
+55% +$44.7K ﹤0.01% 3259
2018
Q4 		$56K Buy
49,100
+10,400
+27% +$16.2K ﹤0.01% 3285
2018
Q3 		$86K Sell
38,700
-71,100
-65% -$164K ﹤0.01% 3252
2018
Q2 		$269K Sell
109,800
-55,800
-34% -$714K ﹤0.01% 3001
2018
Q1 		$2.14M Buy
165,600
+49,000
+42% +$612K ﹤0.01% 2299
2017
Q4 		$1.29M Buy
116,600
+15,600
+15% +$174K ﹤0.01% 2566
2017
Q3 		$1.27M Buy
101,000
+62,500
+162% +$810K ﹤0.01% 2487
2017
Q2 		$439K Buy
38,500
+18,398
+92% +$207K ﹤0.01% 2797
2017
Q1 		$267K Buy
+20,102
New +$232K ﹤0.01% 2939

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Renaissance Technologies's SMMT Position: Q1 2023 in Review

Renaissance Technologies sold out of Summit Therapeutics (SMMT) in Q1 2023, closing a stake of 23,300 shares — an estimated $99K sold.

Renaissance Technologies first reported a position in SMMT in Q1 2017 and held it in 20 quarters. The position peaked at $2.14M in Q1 2018. 91 funds tracked by Wall St. Rank hold SMMT as of Q1 2023.

  • Renaissance Technologies reported no remaining Summit Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Renaissance Technologies sold 23,300 Summit Therapeutics shares in Q1 2023, an estimated $99K.
  • Renaissance Technologies first reported a position in Summit Therapeutics in Q1 2017 and held it in 20 quarters.
  • Renaissance Technologies's Summit Therapeutics position peaked at $2.14M in Q1 2018.
  • 91 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.